Radionuclide Therapy

The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT:

Iodine-131 is considered to be the treatment of choice in many patients with Graves’ disease. The most common side effect of radioactive iodine (RAI) treatment is:

Which of the following property of radiation is principally used in the treatment of tumors?

What is the predominant toxicity of radioisotopes used in the treatment of bone metastases?

A lone “cold” nodule in an otherwise normal thyroid gland warrants:

To reduce radiation exposure to the patient undergoing radioactive iodine (RAI) treatment, all of the following recommendations will be helpful EXCEPT:

According to the Society of Nuclear Medicine “SNM Procedure Guideline for Therapy of Thyroid Disease with I-131 (Sodium Iodide),” typically administered activity for treatment of presumed thyroid cancer in the neck or mediastinal lymph nodes is in the range:

Samarium-153 (Quadramet) is a therapeutic radiopharmaceutical used to treat:

The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT:

An ultimate treatment for patients who are nonresponsive to or cannot tolerate other available therapies for a particular illness and whose prognosis is often poor is called: